Haemophilia Centre Rhine Main

This study is testing a method called immune tolerance induction (ITI) to eliminate inhibitors—antibodies that block standard clotting factor treatment—in 300 people with haemophilia A. The approach uses high doses of clotting factor chosen specifically for each patient based on …